KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Guardant Health (GH) Shares Outstanding (2017 - 2026)

Guardant Health's Shares Outstanding history spans 9 years, with the latest figure at $130.6 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 5.36% to $130.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $130.6 million, a 5.36% increase, with the full-year FY2025 number at $130.6 million, up 5.36% from a year prior.
  • Shares Outstanding hit $130.6 million in Q4 2025 for Guardant Health, up from $125.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding for GH hit a ceiling of $130.6 million in Q4 2025 and a floor of $101.1 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $113.5 million across 5 years, with a median of $117.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding: increased 0.78% in 2022 and later rose 18.58% in 2024.
  • Tracing GH's Shares Outstanding over 5 years: stood at $101.8 million in 2021, then rose by 0.84% to $102.6 million in 2022, then rose by 18.53% to $121.6 million in 2023, then increased by 1.94% to $124.0 million in 2024, then grew by 5.36% to $130.6 million in 2025.
  • Business Quant data shows Shares Outstanding for GH at $130.6 million in Q4 2025, $125.0 million in Q3 2025, and $124.5 million in Q2 2025.